Get started
Author

Wendie D. den Brok

Observed names: WD den Brok, Wendie Brok, Wendie Den Brok, Wendie DenBrok, Wendie den Brok, Wendie denBrok
Institution: BC Cancer Agency
OpenAlex ID: A5033784178
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
2016 · Wendie D. den Brok, Caroline H. Speers, et al. · Breast Cancer Research and Treatment · 188
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2017 · Eric Y. Zhao, Yaoqing Shen, et al. · Clinical Cancer Research · 183
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
2024 · Adam J. Widman, Minita Shah, et al. · Nature Medicine · 138
PDF
Homologous Recombination Deficiency in Breast Cancer: A Clinical Review
2017 · Wendie D. den Brok, Kasmintan A. Schrader, et al. · JCO Precision Oncology · 88
Are two heads better than one? Comparing dyad and self‐regulated learning in simulation training
2013 · David Shanks, Ryan Brydges, et al. · Medical Education · 51
PDF
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma
2020 · Diego Villa, Laurie H. Sehn, et al. · Blood Advances · 35
PDF
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
2024 · Elena Zaikova, Brian Y. C. Cheng, et al. · npj Breast Cancer · 25
PDF
Detection of circulating plasma tumour mutations in early stage triple negative breast cancer as an adjunct to pathological complete response assessment
2023 · Elena Zaikova, Brian Y.C Cheng, et al. · medRxiv · 1
PDF
Abstract 638: Clinical characteristics of breast cancer xenograft models
2016 · Wendie D. den Brok, Stephen Chia, et al. · Cancer Research · 1
Targeting triple-negative breast cancer: optimizing therapeutic outcomes – UPDATE
2016 · Wendie Brok · Medical Research Archives · 1
Board 423 - Research Abstract Thinking on Task
2013 · David Shanks, Rose Hatala, et al. · Simulation in Healthcare The Journal of the Society for Simulation in Healthcare · 1
Supplementary Information from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023 · Eric Y. Zhao, Yaoqing Shen, et al.
PDF
Supplementary Table 5 from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023 · Eric Y. Zhao, Yaoqing Shen, et al.
Data from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023 · Eric Y. Zhao, Yaoqing Shen, et al.
Data from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023 · Eric Y. Zhao, Yaoqing Shen, et al.
Supplementary Table 5 from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023 · Eric Y. Zhao, Yaoqing Shen, et al.
Supplementary Information from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023 · Eric Y. Zhao, Yaoqing Shen, et al.
Abstract P3-08-13: Exploring the role of ctDNA in triple negative breast cancer
2019 · WD den Brok, E Kong, et al. · Cancer Research
Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?”
2017 · Wendie D. den Brok, Caroline H. Speers, et al. · Breast Cancer Research and Treatment
The Long and Winding Road
2014 · Wendie DenBrok, Christine Simmons, et al. · Journal of Clinical Oncology
PDF
Works count: 20
Citation count: 712
H-index: 7
I10-index: 7
Year
Topic
Type